Leveraging hallmark Alzheimer’s molecular targets using phytoconstituents: Current perspective and emerging trends
<p dir="ltr">Alzheimer's disease (AD), a type of dementia, severely distresses different brain regions. Characterized by various neuropathologies, it interferes with cognitive functions and neuropsychiatrical controls. This progressive deterioration has negative impacts not only...
Saved in:
| Main Author: | Prajakta A. Dhage (17302789) (author) |
|---|---|
| Other Authors: | Archana A. Sharbidre (17302792) (author), Sarada P. Dakua (17302795) (author), Shidin Balakrishnan (14150580) (author) |
| Published: |
2021
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
by: Nour K. Majbour (8809316)
Published: (2017) -
Anti-amyloid monoclonal antibody therapies in Alzheimer’s disease – a scoping review
by: Shahd Abubaker Elamin (22569539)
Published: (2025) -
Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice
by: Ann Van der Jeugd (18629695)
Published: (2018) -
Tau deletion promotes brain insulin resistance
by: Elodie Marciniak (18892114)
Published: (2017) -
Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
by: Christopher Hatton (9107257)
Published: (2020)